Literature DB >> 2394450

Prenatal diagnosis of genodermatoses by ultrastructural diagnostic markers in extra-embryonic tissues: defective hemidesmosomes in amnion epithelium of fetuses affected with epidermolysis bullosa Herlitz type (an alternative prenatal diagnosis in certain cases).

I Hausser1, I Anton-Lamprecht.   

Abstract

We report the first use of amnion epithelium for prenatal diagnosis. Prenatal diagnosis of recessive epidermolysis bullosa atrophicans generalisata gravis Herlitz type can at present be achieved with safety by detailed ultrastructural analysis of fetal skin. Because of the close developmental origin of amnion and skin, which has been elucidated by the recent development of anti-amnion antibodies against dermo-epidermal junction antigens and by their abnormal binding in epidermolysis bullosa skin, there is presumably some morphological relationship between amnion epithelium and skin. In a comparative study of extra-embryonic tissues, we found ultrastructurally complete hemidesmosomes in all 24 investigated normal amnion samples from gestational weeks 15-27, but not in 7 reflected chorion samples from weeks 16-22. The results of placental chorion samples were not reliable. Amnion of 5 fetuses affected with epidermolysis bullosa atrophicans generalisata gravis revealed only hypoplastic hemidesmosomes, the same defect as in the respective skin. In a recent case where unfortunately only non-skin material was available, a positive prenatal diagnosis of epidermolysis bullosa atrophicans gravis Herlitz was performed from the amnion material. The diagnosis was confirmed by investigation of the fetal skin after termination. Investigation of amnion membranes is therefore an alternative for prenatal diagnosis of epidermolysis bullosa atrophicans gravis Herlitz in certain cases. The possibility and limitations of the general use of amnion for prenatal diagnosis are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2394450     DOI: 10.1007/bf00206763

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes.

Authors:  P Verrando; B L Hsi; C J Yeh; A Pisani; N Serieys; J P Ortonne
Journal:  Exp Cell Res       Date:  1987-05       Impact factor: 3.905

2.  Prenatal diagnosis of junctional epidermolysis bullosa Herlitz type.

Authors:  I Hausser; I Anton-Lamprecht; B Gustavii
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

3.  Fine structure of human amniotic epithelium in early pregnancy.

Authors:  A D Hoyes
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-09

Review 4.  Prenatal diagnosis of inherited epidermolyses.

Authors:  I Anton-Lamprecht; M L Arnold
Journal:  Curr Probl Dermatol       Date:  1987

5.  Approaches to the study of epidermolysis bullosa.

Authors:  R A Eady; M J Tidman; A H Heagerty; A R Kennedy
Journal:  Curr Probl Dermatol       Date:  1987

6.  Abnormal binding of an anti-amnion antibody to epidermal basement membrane provides a novel diagnostic probe for junctional epidermolysis bullosa.

Authors:  A R Kennedy; A H Heagerty; J P Ortonne; B L Hsi; C J Yeh; R A Eady
Journal:  Br J Dermatol       Date:  1985-12       Impact factor: 9.302

7.  [Ultrastructure of epidermolyses with junctional blister formation (author's transl)].

Authors:  I Anton-Lamprecht; U W Schnyder
Journal:  Dermatologica       Date:  1979

8.  Comparative ultrastructure of the mammalian amnion.

Authors:  R M Wynn; G L French
Journal:  Obstet Gynecol       Date:  1968-06       Impact factor: 7.661

9.  Human amniochorion: tissue-specific markers, transferrin receptors and histocompatibility antigens.

Authors:  B L Hsi; C J Yeh; W P Faulk
Journal:  Placenta       Date:  1982 Jan-Mar       Impact factor: 3.481

10.  Characterization of antibodies to antigens of the human amnion.

Authors:  B L Hsi; C J Yeh; W P Faulk
Journal:  Placenta       Date:  1984 Nov-Dec       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.